Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary
Date: January 24, 2022
Attention: Primary care providers
Effective Date: January 3, 2022Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.
Call to action: HHSC added Molnupiravir to the Medicaid and Children’s Health Insurance Program (CHIP) formulary as a payable pharmacy benefit on January 3rd, 2021. Molnupiravir is indicated to treat individuals with a confirmed diagnosis of COVID-19 who are at high risk for progression to severe COVID-19 and for whom alternative treatment options authorized by the FDA are not accessible or clinically appropriate.
HHSC added the following national drug codes (NDC) for Molnupiravir:
Drug name
Dosage
Package Size
NDC
Molnupiravir EUA
200 mg
40 capsules
00006-5055-06
The dosage for Molnupiravir is 800 mg (four 200mg capsules) taken orally every 12 hours for 5 days.
How this impacts providers: Molnupiravir requires a prescription and should be initiated after diagnosis of COVID-19 and within 5 days of symptom onset. The medication is not authorized for the prevention of COVID-19. Providers can find more information at the DSHS Therapeutics website, which includes a map of pharmacies where DSHS has distributed Molnupiravir for the week of December 27, 2021, and an update on the recently authorized therapeutics for COVID-19. DSHS will revise the site when they distribute additional allocations of Molnupiravir in the coming weeks
Next steps for providers: Providers should share this update with their staff as well
If you have any questions, please email Provider Network Management at: providerrelations@texaschildrens.org.
For access to all provider alerts, log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.
